Results 141 to 150 of about 5,456,142 (288)

Editorial: Emerging therapeutic approaches for non-alcoholic fatty liver disease

Frontiers in Medicine
Mohamed El-Kassas, Mohamed El-Kassas, Mohamed El-Kassas, Khalid Alswat, Khalid Alswat   +4 more
doaj   +1 more source

Handbook of liver disease /

Well-organized and vibrantly illustrated throughout, Handbook of Liver Disease is a comprehensive yet concise handbook providing authoritative guidance on key clinical issues in liver disease.
Friedman, Lawrence S.(Lawrence Samuel),editor., Martin, Paul,M.D.,editor.   +1 more
core  

Divergent Obesity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model

Obesity, EarlyView.
ABSTRACT Objective BMI alone does not capture obesity‐related health heterogeneity. The Edmonton Obesity Staging System (EOSS) grades obesity severity based on comorbidities and functional impairment, whereas the Lancet Commission Diagnostic Model for Obesity (DMO) distinguishes preclinical from clinical obesity based on organ dysfunction.
Tobias Hagemann, Arya M. Sharma, Matthias Blüher, Anne Hoffmann   +3 more
wiley   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

Portal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Immunopathogenesis of liver fibrosis in steatotic liver disease

Clinical and Molecular Hepatology
Chaerin Woo, Won-Il Jeong
openaire   +3 more sources

Hope on the Horizon: Promising Therapies for Steatotic Liver Disease

Steatotic liver disease (SLD) is a highly prevalent chronic liver disease with significant challenges for global health. The pathophysiology of SLD involves an interplay among genetic, endocrine, and metabolic factors.
Eid, Ali H., Sahebkar, Amirhossein
core   +1 more source

Sleep Hygiene in Pediatric Patients with Steatotic Liver Disease [PDF]

J Clin Res Pediatr Endocrinol
Finsterer J.
europepmc   +1 more source

HSPE1 deficiency underlies the crosstalk between metabolic dysfunction‐associated steatotic liver disease and age‐related macular degeneration

VIEW, EarlyView.
Rare‐earth ions act as multifunctional modifiers in perovskite solar cells by improving charge transport, suppressing oxygen vacancies, passivating defects, promoting grain growth, and enabling redox‐mediated stabilization. In addition, RE‐doped layers can expand spectral utilization through upconversion and downconversion, thereby enhancing light ...
Jiaqi Meng, Alimire Maihemuti, Yuan Yuan, Chao Chen, Mengchao Zhu, Hao Wang, Furong Zhu, Zhaodi Che, Jia Xiao, Xiangjia Zhu   +9 more
wiley   +1 more source

Nutrition in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). [PDF]

J Nutr Metab
Nonga D, Gisser J, Chaves E, DiPangrazio A, Lehman A, Pandurangi S, Hassan S, Chu C, Flores A.   +8 more
europepmc   +1 more source

Perioperative Outcomes of Patients With Pancreatic Neuroendocrine Neoplasms in the Context of Different Body Composition Phenotypes

World Journal of Surgery, EarlyView.
Pancreatic neuroendocrine neoplasms (pNEN) are rare and heterogeneous tumors with increasing incidence. While surgical resection remains the only curative treatment, perioperative outcomes are influenced by patient‐related risk factors. Recent research highlights body composition (BC) as a prognostic marker in oncological and transplantation surgery ...
Fabiola A. Bechtiger, Mariah Herbrich, Hazem K. A. A. Hassan, Jörg Kaiser, Thomas Hank, Magdalena Lewosinska, Deniz Uluk, Osman Öcal, Nicole D. Hildebrand, Steven WM Olde Damink, Franck Billmann, Zoltan Czigany, Mohammed Al‐Saeedi   +12 more
wiley   +1 more source